Dopamine: A New Player in the Pathogenesis of Diabetic Retinopathy?
Marianthi Ntikoudi, Theofano Myrto Farmaki, Konstantinos Tziomalos · 2024
Read Dopamine: A New Player in the Pathogenesis of Diabetic Retinopathy? by Marianthi Ntikoudi, Theofano Myrto Farmaki, Konstantinos Tziomalos (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642112.txt.
Description
Marianthi Ntikoudi, Theofano Myrto Farmaki, and Konstantinos Tziomalos published this short review in 2024. Diabetic retinopathy is a leading cause of blindness, and many factors behind it are still not fully known. Treatment options are therefore limited. Recent data suggest that dopamine, a messenger better known from the brain, might play a role in how the eye disease grows. The review gathers and weighs that evidence. It also comments on whether changing dopamine signaling could one day help manage this eye complication of diabetes.
Catalog record
| CREATOR | Marianthi Ntikoudi, Theofano Myrto Farmaki, Konstantinos Tziomalos |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |